Nuofu Zhang to Humans
This is a "connection" page, showing publications Nuofu Zhang has written about Humans.
Connection Strength
0.046
-
Improved night shift schedule related to the mortality of critically ill patients with Corona Virus Disease 2019. Sleep Med. 2020 11; 75:354-360.
Score: 0.007
-
Validation of the NoSAS Score for the Screening of Sleep-Disordered Breathing: A Hospital-Based Retrospective Study in China. J Clin Sleep Med. 2018 02 15; 14(2):191-197.
Score: 0.006
-
Secondary infection in severe and critical COVID-19 patients in China: a multicenter retrospective study. Ann Palliat Med. 2021 Aug; 10(8):8557-8570.
Score: 0.002
-
Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China. Clin Respir J. 2021 Aug; 15(8):915-924.
Score: 0.002
-
Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro. Signal Transduct Target Ther. 2021 03 02; 6(1):104.
Score: 0.002
-
Addendum: Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2021 02 01; 12(1):826.
Score: 0.002
-
Pulmonary Vasculature: A Target for COVID-19. Am J Respir Crit Care Med. 2021 01 15; 203(2):260-261.
Score: 0.002
-
Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):71-78.
Score: 0.002
-
Symptomless multi-variable apnea prediction index assesses adverse outcomes in patients with Corona Virus Disease 2019. Sleep Med. 2020 11; 75:294-300.
Score: 0.002
-
Clinical application of an intelligent oropharyngeal swab robot: implication for the COVID-19 pandemic. Eur Respir J. 2020 Aug; 56(2).
Score: 0.002
-
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020 08 01; 180(8):1081-1089.
Score: 0.002
-
Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2020 07 15; 11(1):3543.
Score: 0.002
-
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020 06; 55(6).
Score: 0.002
-
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 05; 55(5).
Score: 0.002
-
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020 Jul; 146(1):89-100.
Score: 0.002
-
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020 07; 158(1):97-105.
Score: 0.002
-
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020 05; 7(5):e362-e363.
Score: 0.002
-
Transcatheter Autologous Transfusion to Maintain Pulmonary Circulation During Balloon Pulmonary Angioplasty. JACC Cardiovasc Interv. 2018 08 27; 11(16):e127-e128.
Score: 0.002
-
Pulmonary Capillary Hemangiomatosis without Pulmonary Hypertension: An Early Stage of Disease? Chin Med J (Engl). 2018 Jan 20; 131(2):245-246.
Score: 0.002
-
Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism. Clin Chim Acta. 2016 Aug 01; 459:25-29.
Score: 0.001
-
[Research progress in pulmonary hypertension associate with intermittent hypoxia]. Zhonghua Jie He He Hu Xi Za Zhi. 2015 Oct; 38(10):780-2.
Score: 0.001